Orthofix International | OFIX - Current Liabilities


Orthofix International reported $161.03M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Accuray USD 194.61M 2.03M Sep/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 101.56M 15.72M Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Dexcom USD 2.22B 81.3M Mar/2026
EDAP TMS EUR 31.4M 2.71M Sep/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 346.85M 109.14M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 161.03M 9.45M Mar/2026
Plus Therapeutics USD 12.31M 1.3M Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
STAAR Surgical USD 68.5M 6.87M Dec/2025
Stryker USD 6.32B 1.48B Mar/2026
Surmodics USD 19.44M 1.1M Jun/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Veracyte USD 59.94M 12.22M Dec/2025
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026